Mr Bertrand Bolduc joins Pharma in silica inc.'s board of directors

Québec City, September 23, 2019 – Pharma in silica inc. announces today the addition of mister Bertrand Bolduc, pharmacist and experienced entrepreneur to its board of directors.

He joins the directors François Arcand (Pharma in silica), Michel L'Heureux (Valro), Mathieu Poirier (Pfizer), Hugo St-Laurent (SiliCycle) and Guillaume Thivierge (Clean Technologies).

« Bertrand brings to Pharma in silica his sagacity, his deep knowledge of therapeutic actives and his expertise in life sciences: corporate governance, regulatory pathways, good manufacturing practices and business strategies », stated François Arcand, the young enterprise's president.

Pharma in silica is a preclinical stage company based in Québec City's Parc Technologique. It develops a novel drug nanocarrier made of minute silica spheres. The company intends to reduce the toxicity and increase the efficacy of chemotherapy drugs.

About Pharma in silica inc.

Laboratoires Pharma in silica inc. is a preclinical-stage pharmaceutical company based in Québec City's Parc Technologique. Since 2019, it has been developing novel treatments for solid cancers (lung, breast, etc.) using OpPacli™, a patented drug nanocarrier. The company is driven by a dynamic group of chemists, pharmacists and managers led by François Arcand, an experienced life sciences entrepreneur (Medicago, Conferences on Plant-made Pharmaceuticals, ERA Biotech). The company established its own research and production facilities and collaborates with oncology experts and world-renowned research centers and has completed the pre-IND/CTA meetings with the FDA and Health Canada.

For more information

François Arcand
President, Pharma in silica inc
514 994 1023 / 418 874-0054 #233
info@pharma-insilica.com

> all news